Certolizumab Subcutaneous and Dexbrompheniramine and phenylephrine
Determining the interaction of Certolizumab Subcutaneous and Dexbrompheniramine and phenylephrine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Certolizumab Subcutaneous-Dexbrompheniramine and Phenylephrine Syrup
- Certolizumab Subcutaneous-Dexbrompheniramine and Phenylephrine Tablets
- Certolizumab Subcutaneous-Dexbrompheniramine and pseudoephedrine
- Certolizumab Subcutaneous-Dexbrompheniramine and Pseudoephedrine Solution
- Certolizumab Subcutaneous-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Certolizumab Subcutaneous-Dexbrompheniramine and Pseudoephedrine Tablets
- Dexbrompheniramine and phenylephrine-Certolizumab Vials
- Dexbrompheniramine and phenylephrine-Cerubidine
- Dexbrompheniramine and phenylephrine-Cervarix
- Dexbrompheniramine and phenylephrine-Cervarix Intramuscular
- Dexbrompheniramine and phenylephrine-Cervidil
- Dexbrompheniramine and phenylephrine-Cesamet